C M BIDWELL & ASSOCIATES LTD
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1091860
HONOLULU, HI
Position in VRTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,967
+$502 QoQ
Shares Held
10
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,633
of 1,705 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026C M BIDWELL & ASSOCIATES LTD holds $723,217 across 14 Biotechnology names. VRTX ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
5,255 | $368,007 | |
| 2 | INCY |
Incyte Corp
|
2,136 | $242,136 | |
| 3 | EXEL |
Exelixis, Inc.
|
1,452 | $79,003 | |
| 4 | MNPR |
Monopar Therapeutics
|
94 | $8,703 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
64 | $5,220 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
10 | $4,967 | |
| 7 | ENTA |
Enanta Pharmaceuticals Inc
|
331 | $4,825 | |
| 8 | GERN |
Geron Corp
|
3,682 | $4,712 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,967 | 10 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,465 | 10 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,533 | 10 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,916 | 10 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,452 | 10 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,848 | 10 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,027 | 10 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,650 | 10 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,687 | 10 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,180 | 10 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $388,986 | 956 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $330,005 | 949 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $341,352 | 970 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $92,945 | 295 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $85,190 | 295 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $85,414 | 295 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,817 | 10 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,609 | 10 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,196 | 10 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,813 | 10 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,016 | 10 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,148 | 10 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $160,947 | 681 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $195,926 | 720 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $467,108 | 1,609 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $642,465 | 2,700 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||